domingo, 27 de abril de 2025

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-penpulimab-kcqx-non-keratinizing-nasopharyngeal-carcinoma?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario